
Domperidone (10mg) + Pantoprazole (40mg)
Active composition
+1 more active ingredient
Domperidone antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, inhibiting nausea and vomiting.
Pantoprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, leading to decreased gastric acid secretion.
Medical applications
Zopantol-D Tablet is a combination pharmaceutical formulation containing Domperidone 10 mg and Pantoprazole 40 mg, indicated for the management of gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a significant reduction in gastric acidity. The synergistic action of these two agents provides effective relief from acid reflux, heartburn, and associated upper gastrointestinal discomfort. Zopantol-D is typically prescribed for short to medium-term use under medical supervision, with dosage adjusted based on clinical response. It is contraindicated in patients with hypersensitivity to either component, and caution is advised in those with hepatic impairment. Common adverse effects may include headache, dry mouth, and abdominal cramps. Patients should be advised to adhere to prescribed dosages and report any unusual symptoms to their healthcare provider promptly.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Zopantol-D Tablet

Domperidone (10mg) + Pantoprazole (40mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Domperidone antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, inhibiting nausea and vomiting.
Pantoprazole irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, leading to decreased gastric acid secretion.
Medical applications
Zopantol-D Tablet is a combination pharmaceutical formulation containing Domperidone 10 mg and Pantoprazole 40 mg, indicated for the management of gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a significant reduction in gastric acidity. The synergistic action of these two agents provides effective relief from acid reflux, heartburn, and associated upper gastrointestinal discomfort. Zopantol-D is typically prescribed for short to medium-term use under medical supervision, with dosage adjusted based on clinical response. It is contraindicated in patients with hypersensitivity to either component, and caution is advised in those with hepatic impairment. Common adverse effects may include headache, dry mouth, and abdominal cramps. Patients should be advised to adhere to prescribed dosages and report any unusual symptoms to their healthcare provider promptly.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Zopantol-D Tablet















